The Natural Medicine Alliance of Idaho has reported collecting over 150,000 signatures in support of the Idaho Medical Cannabis Act, an initiative aimed at legalizing medical cannabis for patients in Idaho. This milestone follows the conclusion of the initiative’s signature gathering period last week, moving the proposal closer to potential inclusion on the state’s November ballot.
Initiative Progress and Verification
The Natural Medicine Alliance of Idaho announced that more than 150,000 signatures were submitted to the Secretary of State’s office, as reported by KTVB. To qualify for the ballot, the initiative requires 70,725 valid signatures, which is equivalent to 6% of the registered voters statewide, with an additional stipulation that this 6% threshold must be met in at least 18 of Idaho’s 35 legislative districts, according to Ganjapreneur.
County clerks are currently undertaking the verification process for these signatures. The IdahoPress reported that this verification is expected to be completed by June 30, after which valid signatures will be submitted to the Idaho Secretary of State’s office to determine the initiative’s qualification status for the November ballot. KTVB noted that county clerks have 60 days from the May 1 submission deadline to verify the signatures, and also mentioned that if approved, the petition could qualify for the November 2026 ballot.
Amanda Watson, communications lead for the Natural Medicine Alliance of Idaho, stated, “This milestone belongs to the tens of thousands of Idahoans who signed. Together, we have moved the Idaho Medical Cannabis Act one step closer to the ballot and one step closer to a decision made by the people of Idaho themselves. Now we await the count, and the chance to bring this issue before voters in November.”
Provisions of the Idaho Medical Cannabis Act
If enacted, the Idaho Medical Cannabis Act would establish a framework for regulated access to medical cannabis for patients with “substantial health conditions.” These conditions, as outlined in a prior release from the organization, include cancer, epilepsy, AIDS, anxiety, post-traumatic stress disorder, chronic pain, autism, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and terminal illness.
Under the proposed act, qualifying individuals would need to obtain a medical cannabis card by providing medical records to a practitioner qualified to make such a diagnosis. The application for approval would then be submitted to the Idaho Department of Health and Welfare. Access to medical cannabis would not require a prescription. The act also directs the creation of a medical cannabis production license, which would permit the growth, transport, manufacturing, distribution, and sale of cannabis to approved medical cannabis cardholders. KTVB reported that the Idaho Board of Pharmacy would be granted oversight authority, licensing and regulating these producers, who would be subject to criminal background checks, security plans, routine inspections, and oversight by a licensed pharmacist. The initiative would provide legal protections for patients, doctors, pharmacists, caregivers, and licensed businesses operating within the law.
The act maintains existing bans on recreational use. Public consumption, including smoking or vaping cannabis in public places, would remain a misdemeanor, and driving under the influence of cannabis would continue to be a criminal offense. Strict monthly possession limits are also stipulated. The provisions for card issuance are proposed to commence on July 1, 2027.
Legislative Opposition and Funding
In response to the ballot initiative’s progress, the Idaho Legislature adopted a concurrent resolution in April. This resolution outlined legislative findings on the Idaho Medical Cannabis Act and urged Idahoans to reject the measure. The resolution claimed that cannabis legalization has been associated with increased cartel activity, health issues including psychosis, and illegal grow sites. It also suggested that the implementation of a statewide medical cannabis program would impose a financial burden on the Idaho Department of Health and Welfare and other agencies tasked with its administration.
The ballot proposal addresses administrative costs by stipulating that the program will be funded through fees associated with medical cannabis cards, as reported by IdahoPress.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
